サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414282

ヘルパンギーナ治療の世界市場レポート 2024年

Herpangina Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヘルパンギーナ治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ヘルパンギーナ治療市場規模は近年力強く成長しています。2023年の17億6,000万米ドルから2024年には18億8,000万米ドルへ、CAGR6.9％で拡大する見込みです。過去の期間に見られた拡大は、ウイルスの発生と流行、小児人口の増加、医療インフラの開発、公衆衛生の意識向上プログラム、ヘルパンギーナの臨床研究と治療の進歩などの要因によるものです。

ヘルパンギーナ治療市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR 7.0％で24億7,000万米ドルに成長します。予測期間中に予想される成長は、新型ウイルス株の出現、小児医療への関心の高まり、国際保健規制の遵守、診断における技術革新、医療アクセスの改善などの要因によるものと考えられます。予測期間中に予想される世界の動向には、口腔病変に対する局所療法の開発、診断と相談のための遠隔医療の統合、患者教育と意識向上プログラムの強化、臨床試験と研究のための連携、国際保健対策への取り組みなどが含まれます。

ヘルパンギーナ治療市場は、ヘルパンギーナの有病率の増加により成長が見込まれています。ヘルパンギーナは、一般的に小児が罹患するウイルス性疾患で、扁桃腺や喉の奥に痛みを伴うただれや潰瘍を引き起こし、一般的にはコクサッキーウイルスやエンテロウイルスが原因とされます。ヘルパンギーナ治療は、水疱、高熱、口やのどの不快感、よだれ、食欲不振などの症状を緩和することを目的としています。国立医学図書館によると、中国では、コクサッキーウイルス（Cox A16）症例発生率は2020年と比較して2021年には1.09症例（1/100,000）に増加し、その他のエンテロウイルス症例は2020年の4.46症例（1/100,000）から2021年には4.73症例（1/100,000）に増加しており、ヘルパンギーナ症例の急増を示し、市場の成長を牽引しています。

ヘルパンギーナ治療市場の成長は、小児人口の増加によっても促進されると予想されます。出生から思春期または成熟期までの個人を網羅するこの人口層は、ヘルパンギーナ治療において症状管理、支持療法、適切な水分補給の確保に焦点を当てた特別な注意を必要とします。連邦児童・家族統計機関間フォーラムによると、2022年の米国の小児人口は約7,250万人で、2050年には7,820万人に増加すると予測されています。このような小児人口の増加は、ヘルパンギーナ治療市場の成長を大きく促進する要因となっています。

北米は、2023年の世界ヘルパンギーナ治療市場において最大の地域でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。ヘルパンギーナ治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界のヘルパンギーナ治療市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 表面麻酔剤
  • イブプロフェン/アセトアミノフェン
  • その他
  • 世界のヘルパンギーナ治療市場、ウイルス別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • コクサッキーウイルスA
  • コクサッキーウイルスB
  • エンテロウイルス71
  • エコーウイルス
  • 世界のヘルパンギーナ治療市場、症状別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 高熱
  • 喉の痛み
  • 口腔内・咽頭の水疱や潰瘍
  • 嚥下困難
  • 食欲減少
  • 首の痛み
  • リンパ腺の腫れ
  • 頭痛
  • 世界のヘルパンギーナ治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 在宅ケア
  • 専門クリニック
  • その他

第7章 地域および国の分析

  • 世界のヘルパンギーナ治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のヘルパンギーナ治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ヘルパンギーナ治療市場の競合情勢
  • ヘルパンギーナ治療市場の企業プロファイル
    • Gilead Sciences Inc.
    • Johnson and Johnson Services Inc.
    • Merck & Co. Inc.
    • Pfizer Inc.
    • AbbVie Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r11792

“Herpangina Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on herpangina treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for herpangina treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The herpangina treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Treatment: Topical Anesthetics; Ibuprofen Or Acetaminophen; Other Treatments
  • 2) By Virus: Coxsackie Virus A; Coxsackie Virus B; Enterovirus 71; Echovirus
  • 3) By Symptoms: High Fever; Sore Throat; Blisters Or Ulcers In The Throat Mouth; Difficulty Swallowing; Loss Of Appetite; Neck Pain; Swollen Lymph Glands; and Headache
  • 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End-Users
  • Companies Mentioned: Gilead Sciences Inc.; Johnson and Johnson Services Inc.; Merck & Co. Inc.; Pfizer Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Herpangina treatment involves managing the symptoms of the viral illness that commonly affects children, causing painful sores or ulcers on the tonsils and the back of the throat. Treatment focuses on alleviating symptoms and supporting the body's natural healing process, as herpangina is a viral infection that typically resolves on its own without the need for specific antiviral medications.

The main types of herpangina treatment include topical anesthetics, ibuprofen or acetaminophen, and others. Topical anesthetics are a form of local anesthesia applied to the skin's surface or mucous membrane to temporarily numb the affected region. Herpangina is caused by viruses such as coxsackie virus A, coxsackie virus B, enterovirus 71, and echovirus, leading to various symptoms such as high fever, sore throat, blisters or ulcers in the throat and mouth, difficulty swallowing, loss of appetite, headache, neck pain, and swollen lymph glands. These treatments are utilized by various end-users, including hospitals, home care settings, specialty clinics, and others.

The herpangina treatment market research report is one of a series of new reports from The Business Research Company that provides herpangina treatment market statistics, including herpangina treatment industry global market size, regional shares, competitors with a herpangina treatment market share, detailed herpangina treatment market segments, market trends and opportunities, and any further data you may need to thrive in the herpangina treatment industry. This herpangina treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The herpangina treatment market size has grown strongly in recent years. It will grow from $1.76 billion in 2023 to $1.88 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%.The expansion observed in the historical period can be attributed to factors such as viral outbreaks and prevalence, the growth of the pediatric population, development in healthcare infrastructure, public health awareness programs, and advancements in clinical research and treatment for herpangina.

The herpangina treatment market size is expected to see strong growth in the next few years. It will grow to $2.47 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The anticipated growth in the forecast period can be attributed to factors such as the emergence of new viral strains, a growing focus on pediatric health, adherence to international health regulations, technological innovations in diagnostics, and improvements in healthcare access. Key trends expected in the forecast period encompass the development of topical therapies for oral lesions, the integration of telemedicine for diagnosis and consultation, enhanced patient education and awareness programs, collaborations for clinical trials and research, and global health preparedness initiatives.

The herpangina treatment market is anticipated to witness growth due to the increasing prevalence of herpangina. Herpangina is a viral illness that commonly affects children, causing painful sores or ulcers on the tonsils and the back of the throat, typically attributed to coxsackievirus and enteroviruses. Treatment for herpangina aims to alleviate symptoms such as blisters, high fever, mouth or throat discomfort, drooling, and loss of appetite. According to the National Library of Medicine, in China, the incidence of Coxsackievirus (Cox A16) cases rose to 1.09 cases (1/100,000) in 2021 compared to 2020, and other enterovirus cases increased from 4.46 cases (1/100,000) in 2020 to 4.73 cases (1/100,000) in 2021, indicating a surge in herpangina cases and driving market growth.

The growth of the herpangina treatment market is also expected to be fueled by the increasing pediatric population. This population segment, encompassing individuals from birth to adolescence or maturity, requires specific attention in herpangina treatment, focusing on symptom management, supportive care, and ensuring proper hydration. The Federal Interagency Forum on Child and Family Statistics reported around 72.5 million children in the United States in 2022, with a projected increase to 78.2 million by 2050. This rise in the pediatric population is a significant driver for the growth of the herpangina treatment market.

The growth of the herpangina treatment market is expected to be propelled by a surge in healthcare expenditure. Healthcare expenditure encompasses all costs related to health services, nutrition activities, family planning, and emergency aid designated for health. An increase in healthcare spending can contribute to the expansion of resources and the availability of trained healthcare professionals for herpangina treatment. According to the Centers for Medicare & Medicaid Services, the National Health Expenditure (NHE) increased by 2.7% to $4.3 trillion in 2021, reaching $12,914 per person. Projected annual increases of 5.1 percent and a 19.6 percent share of GDP in 2030 indicate sustained growth in healthcare expenditure, driving the herpangina treatment market.

The development of treatments for herpangina-related diseases, such as aphthous stomatitis, is a notable trend gaining traction in the herpangina treatment market. Major companies in the market are actively working on therapies to alleviate pain in individuals with recurrent mouth ulcers. For instance, in September 2022, Mucocort, a Sweden-based healthcare company, partnered with Aurena Laboratories AB to create a unique self-absorbing pain relief patch for individuals suffering from recurrent mouth ulcers and aphthous stomatitis, facilitating pain relief and accelerating the natural healing process.

Key players in the herpangina treatment market are focusing on the development of new treatments, including Acetaminophen pain relief products for adults. These products, containing acetaminophen as the active ingredient, aim to relieve pain and reduce fever. In April 2022, Genexa, a US-based pharmaceutical company, introduced 'Genexa Acetaminophen Extra Strength' and 'Acetaminophen PM caplets' for temporary relief from minor aches, discomfort associated with conditions such as the common cold, headaches, backaches, arthritis pain, toothaches, muscular aches, and premenstrual and menstrual cramps. The launch of such products contributes to the diversification and growth of the herpangina treatment market.

Major companies operating in the herpangina treatment market report are Gilead Sciences Inc., Johnson and Johnson Services Inc., Merck & Co. Inc., Pfizer Inc., AbbVie Inc., Vertex Pharmaceuticals Incorporated, Sanofi S.A, Novartis AG, Mitsubishi Tanabe Pharma Corporation, F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, AstraZeneca plc, Bausch Health Companies Inc., Mylan N.V., GlaxosmithKline plc, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Limited, Macleods Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Jubilant Life Sciences Ltd.

North America was the largest region in the global herpangina treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the herpangina treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the herpangina treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The herpangina treatment market consists of revenues earned by entities by providing medical services such as symptomatic relief, hydration, soft diet, and oral hygiene. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Herpangina Treatment Market Characteristics

3. Herpangina Treatment Market Trends And Strategies

4. Herpangina Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Herpangina Treatment Market Size and Growth

  • 5.1. Global Herpangina Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Herpangina Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Herpangina Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Herpangina Treatment Market Segmentation

  • 6.1. Global Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Topical Anesthetics
  • Ibuprofen Or Acetaminophen
  • Other Treatments
  • 6.2. Global Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Coxsackie Virus A
  • Coxsackie Virus B
  • Enterovirus 71
  • Echovirus
  • 6.3. Global Herpangina Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • High Fever
  • Sore Throat
  • Blisters Or Ulcers In The Throat Mouth
  • Difficulty Swallowing
  • Loss Of Appetite
  • Neck Pain
  • Swollen Lymph Glands
  • and Headache
  • 6.4. Global Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End-Users

7. Herpangina Treatment Market Regional And Country Analysis

  • 7.1. Global Herpangina Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Herpangina Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Herpangina Treatment Market

  • 8.1. Asia-Pacific Herpangina Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Herpangina Treatment Market

  • 9.1. China Herpangina Treatment Market Overview
  • 9.2. China Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Herpangina Treatment Market

  • 10.1. India Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Herpangina Treatment Market

  • 11.1. Japan Herpangina Treatment Market Overview
  • 11.2. Japan Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Herpangina Treatment Market

  • 12.1. Australia Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Herpangina Treatment Market

  • 13.1. Indonesia Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Herpangina Treatment Market

  • 14.1. South Korea Herpangina Treatment Market Overview
  • 14.2. South Korea Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Herpangina Treatment Market

  • 15.1. Western Europe Herpangina Treatment Market Overview
  • 15.2. Western Europe Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Herpangina Treatment Market

  • 16.1. UK Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Herpangina Treatment Market

  • 17.1. Germany Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Herpangina Treatment Market

  • 18.1. France Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Herpangina Treatment Market

  • 19.1. Italy Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Herpangina Treatment Market

  • 20.1. Spain Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Herpangina Treatment Market

  • 21.1. Eastern Europe Herpangina Treatment Market Overview
  • 21.2. Eastern Europe Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Herpangina Treatment Market

  • 22.1. Russia Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Herpangina Treatment Market

  • 23.1. North America Herpangina Treatment Market Overview
  • 23.2. North America Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Herpangina Treatment Market

  • 24.1. USA Herpangina Treatment Market Overview
  • 24.2. USA Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Herpangina Treatment Market

  • 25.1. Canada Herpangina Treatment Market Overview
  • 25.2. Canada Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Herpangina Treatment Market

  • 26.1. South America Herpangina Treatment Market Overview
  • 26.2. South America Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Herpangina Treatment Market

  • 27.1. Brazil Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Herpangina Treatment Market

  • 28.1. Middle East Herpangina Treatment Market Overview
  • 28.2. Middle East Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Herpangina Treatment Market

  • 29.1. Africa Herpangina Treatment Market Overview
  • 29.2. Africa Herpangina Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Herpangina Treatment Market, Segmentation By Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Herpangina Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Herpangina Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Herpangina Treatment Market Competitive Landscape
  • 30.2. Herpangina Treatment Market Company Profiles
    • 30.2.1. Gilead Sciences Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Pfizer Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AbbVie Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Herpangina Treatment Market Competitive Benchmarking

32. Global Herpangina Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Herpangina Treatment Market

34. Herpangina Treatment Market Future Outlook and Potential Analysis

  • 34.1 Herpangina Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Herpangina Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Herpangina Treatment Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer